Dergiler / Medicine Science / 2016 / Cilt: 5 - Sayı: 4

Protective role of caffeic acid phenethyl ester against tetramethrine-induced toxicity in mice

Sayfa
972–978
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We think that CAPE may be used for therapeutic purposes in order to provide a limited protection against the tetramethrine-related detrimental effects in humans and other living organisms

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The purpose of this study was to determine the biochemical, histopathological and genotoxic effects of tetramethrine, which is widely used in domestic and agricultural activities as well as identify the protective effect of caffeic acid phenethyl ester (CAPE). 30 Swiss albino laboratory mice (Mus musculus) were used in the study. 10 ?M/kg tetramethrine, dissolving in 10 mM DMSO (Dimethyl sulfoxide), was intraperitoneally injected to the Tetramethrine group (n = 10).
📊
Temel Bulgular & Veri:To the CAPE-Tetramethrine group, 10 µM / kg-1 CAPE, dissolving in 1% ethanol, was applied in three days before the experiment and then, CAPE and 10 ?M / kg tetramethrine, dissolving in 10 mM DMSO, was intraperitoneally injected.
💡
Sonuç & Katkı:We think that CAPE may be used for therapeutic purposes in order to provide a limited protection against the tetramethrine-related detrimental effects in humans and other living organisms
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

The purpose of this study was to determine the biochemical, histopathological and genotoxic effects of tetramethrine, which is widely used in domestic and agricultural activities as well as identify the protective effect of caffeic acid phenethyl ester (CAPE). 30 Swiss albino laboratory mice (Mus musculus) were used in the study. 10 ?M/kg tetramethrine, dissolving in 10 mM DMSO (Dimethyl sulfoxide), was intraperitoneally injected to the Tetramethrine group (n = 10). To the CAPE-Tetramethrine group, 10 µM / kg-1 CAPE, dissolving in 1% ethanol, was applied in three days before the experiment and then, CAPE and 10 ?M / kg tetramethrine, dissolving in 10 mM DMSO, was intraperitoneally injected. No injection was made to the control group. At the end of the experiment, the rats anaesthetized with diethyl ether were killed by cervical dislocation and their livers and femur were removed for analysis. There was no statistical difference between three groups in terms of mitotic index (MI) and micronucleus frequency (P > 0.05). Chromosomal aberration frequency showed an increase in the other two groups compared to the control group (P < 0.05). Although severe degeneration and necrosis areas were identified in the liver, CAPE decreased the severity of degeneration in the Tetramethrine group. While Tetramethrine increased the malondialdehyde (MDA) level in the liver, CAPE decreased MDA and increased the GSH level. We think that CAPE may be used for therapeutic purposes in order to provide a limited protection against the tetramethrine-related detrimental effects in humans and other living organisms

🔖

Bu Makaleye Atıf Yap

NUR, G., DEVECİ, H. A., ERSAN, Y., MERHAN, O., NAZLI, M., NUR, O. (2016). Protective role of caffeic acid phenethyl ester against tetramethrine-induced toxicity in mice. Medicine Science, Cilt: 5 - Sayı: 4, 972–978. https://ajindex.com/articles/277703

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. WHO. Safety of Pyrethroids for Public Health Use. World Health Organization (WHO/CDS/WHOPES/GCDPP/2005.10) (WHO/PCS /RA/2005.1), 2005.
  2. Casida JE, Quistad GB. Golden Age of Insecticide Research: Past, Present, or Future? Annu Rev Entomol. 1998;43:1-16.
  3. Song JH, Narahashi T. Modulation of Sodium Channels of Rat Cerebellar Pyrkinje Neurons by the Pyrethroid Tetramethrin. J Pharmacol Exp Ther. 1996;227(1):445-53.
  4. Wang X, Bowman PD, Kerwin SM, Stavchansky S. Stability of caffeic acid phenethyl ester and its fluorinated derivative in rat plasma. Biomed Chromatogr. 2007;21(4):343-50.
  5. Russo A, Longo R, Vanella A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia. 2002;73:21-9.
  6. Song YS, Park EH, Hur MH, Ryu YS, Lee YS, Kim YM, Jin C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gen expression and enzyme activation. Cancer Letters. 2002;175(1):53- 61. Jaiswal AK, Venogopal R, Mucho J, Carothers A, Grunderberger D. Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H: quinone oxidoreductase (NQO1) gene. Cancer Res. 1997;57(3):440-6.
  7. Son S, Lobkowsky E, Lewis BA. Caffeic acid phenethyl ester (CAPE): synthesis and x-ray crystallographic analysis. Chem Pharm Bull. 2001;49(2):236-8.
  8. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, Estevez V, Nakanishi K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia. 1998; 44(3):230-2.
  9. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C, Mestre JR, Grunberger D, Sacks PG, Tanabe T, Dannenberg AJ. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in rat model of inflammation. Cancer Res. 1999;59(10):2347-52.
  10. Orban Z, Mitsiades N, Burke Jr. TR, Tsokos M, Chrousos GP. Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute infl ammation. Neuroimmunomodulat. 2000;7(2):99-105.
  11. Fesen MR, Pommier Y, Leteurtre E, Hiroguchi S, Yung J, Kohn KW. Inhibition of HIV-1 integrase by fl avones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol. 1994;48(3):595-608.
  12. Sudina GF, Mirzoeva OK, Pushkareva M.A, Korshunova GA, Sumbatyan NV, Varfolomeev SD. Caffeic acid ester as a lipoxygenase inhibitor with antioxidant properties. Febs Lett. 1993;329(1-2):21-4.
  13. Park JH, L